These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 2803346)

  • 1. Lipids, lipoproteins and apolipoproteins A-I and B and apolipoprotein losses in continuous ambulatory peritoneal dialysis.
    Steele J; Billington T; Janus E; Moran J
    Atherosclerosis; 1989 Sep; 79(1):47-50. PubMed ID: 2803346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apolipoprotein B-containing lipoproteins in renal failure: the relation to mode of dialysis.
    Attman PO; Samuelsson OG; Moberly J; Johansson AC; Ljungman S; Weiss LG; Knight-Gibson C; Alaupovic P
    Kidney Int; 1999 Apr; 55(4):1536-42. PubMed ID: 10201020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipids, lipoproteins and apolipoproteins abnormalities in patients undergoing dialysis.
    Yang X; Wang H; Zhu Z; Deng A
    J Tongji Med Univ; 1997; 17(2):126-8. PubMed ID: 9639806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The uremic dyslipidemia: a cross-sectional and longitudinal study.
    Avram MM; Goldwasser P; Burrell DE; Antignani A; Fein PA; Mittman N
    Am J Kidney Dis; 1992 Oct; 20(4):324-35. PubMed ID: 1415199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal survey of apolipoproteins and atherogenic risk in hemodialysis and continuous ambulatory peritoneal dialysis patients.
    Burrell D; Antignani A; Fein PA; Goldwasser P; Mittman N; Avram MM
    ASAIO Trans; 1990; 36(3):M331-5. PubMed ID: 2123635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variability of peritoneal clearances for apolipoprotein and its relationship to susceptibility for atherosclerotic changes in CAPD.
    Fein PA; Fletcher D; Antignani A; Goldwasser P; Jorden A; Lustig A; Avram MM
    Adv Perit Dial; 1989; 5():185-90. PubMed ID: 2577408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of dialysis type on serum lipids, apolipoproteins, and lipoproteins.
    Kanbay M; Delibasi T; Kaya A; Aydogan T; Koca C; Akcay A; Duranay M; Yigitoglu R
    Ren Fail; 2006; 28(7):567-71. PubMed ID: 17050239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apo AIV in plasma and dialysate fluid of CAPD patients: comparison with other apolipoproteins.
    Kandoussi A; Cachera C; Reade R; Pagniez D; Fruchart JC; Tacquet A
    Nephrol Dial Transplant; 1992; 7(10):1026-9. PubMed ID: 1331878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship between plasma and dialysate lipoproteins and apoproteins in patients treated by continuous ambulatory peritoneal dialysis.
    Henkin Y; Neeman Z; Zuili I; Chaimovitz C; Shany S
    Am J Kidney Dis; 1993 Dec; 22(6):829-34. PubMed ID: 8250029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of variation at the apolipoprotein E locus on lipid and lipoprotein levels in CAPD patients.
    Eggertsen G; Heimbürger O; Stenvinkel P; Berglund L
    Nephrol Dial Transplant; 1997 Jan; 12(1):141-4. PubMed ID: 9027789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipoproteins in children treated with continuous peritoneal dialysis.
    Querfeld U; LeBoeuf RC; Salusky IB; Nelson P; Laidlaw S; Fine RN
    Pediatr Res; 1991 Feb; 29(2):155-9. PubMed ID: 2014151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipoprotein and apolipoprotein losses during continuous ambulatory peritoneal dialysis.
    Saku K; Sasaki J; Naito S; Arakawa K
    Nephron; 1989; 51(2):220-4. PubMed ID: 2915760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Residual renal function affects lipid profile in patients undergoing continuous ambulatory peritoneal dialysis.
    Kagan A; Elimalech E; Lemer Z; Fink A; Bar-Khayim Y
    Perit Dial Int; 1997; 17(3):243-9. PubMed ID: 9237284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of lipid abnormalities in continuous ambulatory peritoneal dialysis and hemodialysis patients.
    Ong-Ajyooth L; Sirisalee K; Shayakul C; Vareesangthip K; Vasuvattakul S; Vanichakarn S; Nimmannit S; Chirawong P; Ong-Ajyooth S; Nilwarangkur S
    Transplant Proc; 1994 Aug; 26(4):2077-9. PubMed ID: 8066677
    [No Abstract]   [Full Text] [Related]  

  • 15. Post-dialysis retention of blood lipoproteins and apolipoproteins in patients with end-stage renal disease on maintenance haemodialysis in Kuwait.
    Al-Rashidi M; Hussain AA; Nampoory MR; Al-Ali JH; Akanji AO
    Clin Chim Acta; 2004 Jun; 344(1-2):149-54. PubMed ID: 15149883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular risk factors in diabetic patients undergoing continuous ambulatory peritoneal dialysis.
    Babazono T; Miyamae M; Tomonaga O; Omori Y
    Adv Perit Dial; 1996; 12():120-5. PubMed ID: 8865885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multicenter study of lipoprotein(a) and apolipoprotein(a) phenotypes in patients with end-stage renal disease treated by hemodialysis or continuous ambulatory peritoneal dialysis.
    Kronenberg F; König P; Neyer U; Auinger M; Pribasnig A; Lang U; Reitinger J; Pinter G; Utermann G; Dieplinger H
    J Am Soc Nephrol; 1995 Jul; 6(1):110-20. PubMed ID: 7579063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apo A1/Apo B ratio and acute coronary syndrome among peritoneal dialysis patients.
    Chen T; Yang M
    Ren Fail; 2021 Dec; 43(1):737-742. PubMed ID: 33913384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of apolipoprotein E genotype on lipid and lipoprotein levels in continuous ambulatory peritoneal dialysis patients.
    Choi KH; Song HY; Shin SK; Noh H; Kang SW; Kim JH; Lee HY; Han DS
    Adv Perit Dial; 1999; 15():243-6. PubMed ID: 10682111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipoprotein(a) and apolipoprotein(a) phenotypes in patients with end-stage renal disease.
    Kim SB; Yang WS; Kang ES; Min WK; Park JS
    Perit Dial Int; 1997; 17(3):236-42. PubMed ID: 9237283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.